ICD-10 Coding for Classic Hodgkin Lymphoma(C81.0, C81.0N, C81.0V)
Learn about ICD-10 coding for classic Hodgkin lymphoma, including subtypes and remission codes. Ensure accurate documentation and compliance.
Complete code families applicable to Classic Hodgkin Lymphoma
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| C81.0 | Nodular lymphocyte predominant Hodgkin lymphoma | Use when biopsy confirms nodular lymphocyte predominant subtype. |
|
| C81.1 | Nodular sclerosis classical Hodgkin lymphoma | Use when biopsy confirms nodular sclerosis subtype. |
|
| C81.9 | Hodgkin lymphoma, unspecified | Use when subtype is not specified in documentation. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information
Essential facts and insights aboutClassic Hodgkin Lymphoma
Alternative codes to consider when ruling out similar conditions
Documentation & Coding Risks
Avoid these common issues when documenting Classic Hodgkin Lymphoma.
Failure to document B symptoms
Impact
Clinical: Inaccurate staging and treatment planning., Regulatory: Non-compliance with staging documentation requirements., Financial: Potential for incorrect DRG assignment.
Mitigation
Ensure B symptoms are assessed and documented at each visit.
Using unspecified code C81.9 when subtype is documented
Impact
Reimbursement: May lead to lower reimbursement rates., Compliance: Non-compliance with coding guidelines., Data Quality: Decreases accuracy of health records.
Mitigation
Ensure documentation specifies subtype and use the appropriate specific code.
Unspecified coding
Impact
Use of unspecified codes when specific subtypes are documented.
Mitigation
Implement regular audits of pathology reports to ensure subtype documentation.